|
2024 Journal Article Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancerYaghoubi Naei, Vahid, Ivanova, Ekaterina, Mullally, William, O'Leary, Connor G, Ladwa, Rahul, O'Byrne, Ken, Warkiani, Majid E and Kulasinghe, Arutha (2024). Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer. Clinical and Translational Immunology, 13 (6) e1516, e1516. doi: 10.1002/cti2.1516 |
|
2023 Journal Article Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoringAhmed, Mostak, Wuethrich, Alain, Constantin, Nicolas, Shanmugasundaram, Karthik Balaji, Mainwaring, Paul, Kulasinghe, Arutha, O’Leary, Connor, O’Byrne, Ken, Sina, Abu Ali Ibn, Carrascosa, Laura G. and Trau, Matt (2023). Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring. Analytical Chemistry, 95 (22), 8522-8532. doi: 10.1021/acs.analchem.3c00519 |
|
2022 Journal Article Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancerKapeleris, Joanna, Bark, Juliana Müller, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O’Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M. and Punyadeera, Chamindie (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8 (7) e09971, 1-9. doi: 10.1016/j.heliyon.2022.e09971 |
|
2021 Journal Article The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, O'Leary, Connor, Monkman, James, Bharti, Vandhana, Irwin, Darryl, Dutta, Sanjay, Richard, Derek J., Hughes, Brett, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer, 160, 73-77. doi: 10.1016/j.lungcan.2021.08.005 |
|
2020 Journal Article High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC)Monkman, James, Taheri, Touraj, Warkiani, Majid Ebrahimi, O’leary, Connor, Ladwa, Rahul, Richard, Derek, O’ Byrne, Ken and Kulasinghe, Arutha (2020). High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC). Cancers, 12 (12) 3551, 1-16. doi: 10.3390/cancers12123551 |
|
2020 Journal Article Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the bloodKulasinghe, Arutha, Monkman, James, Nalder, Mark, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2020). Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood. Reports, 3 (4) 33, 33. doi: 10.3390/reports3040033 |
|
2020 Journal Article Ex vivo culture of circulating tumour cells derived from non-small cell lung cancerKapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid Ebrahimi, Oleary, Connor, Vela, Ian, Leo, Paul, Sternes, Peter, O'Byrne, Kenneth and Punyadeera, Chamindie (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer Research, 9 (5), 1795-1809. doi: 10.21037/tlcr-20-521 |
|
2020 Journal Article Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)O’Leary, Connor, Gasper, Harry, Sahin, Katherine B., Tang, Ming, Kulasinghe, Arutha, Adams, Mark N., Richard, Derek J. and O’Byrne, Ken J. (2020). Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Pharmaceuticals, 13 (10) 273, 1-16. doi: 10.3390/ph13100273 |
